What is the current stock price of Tactile Systems Technology, Inc. (TCMD)?

As of the latest market data, Tactile Systems Technology, Inc. (TCMD) is trading at $24.24. The stock has seen a gain of 3.46% today.

Does Tactile Systems Technology, Inc. (TCMD) pay a dividend?

Based on current data, Tactile Systems Technology, Inc. does not have a confirmed active dividend policy.

What is the market cap of Tactile Systems Technology, Inc.?

The current market capitalization of Tactile Systems Technology, Inc. (TCMD) is approximately unavailable.

TCMD

Tactile Systems Technology, Inc.·Healthcare

24.24

3.457%(+0.81)

Close Price

28.80

18.812%(+4.56)

Pre-Market

Last Updated: — ET

52W L: $8.6152W H: $37.77

TCMD NEWS

defenseworld.net

1d ago

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Brokerages

Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to

zacks.com

5d ago

Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com

Mar 23

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.

defenseworld.net

Mar 19

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Tactile Systems Technology, Inc. (NASDAQ: TCMD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy

zacks.com

Mar 16

Wall Street Analysts See a 41.11% Upside in Tactile Systems Technology (TCMD): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tactile Systems Technology (TCMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com

Mar 9

Tactile Systems Technology (TCMD) is an Incredible Growth Stock: 3 Reasons Why

Tactile Systems Technology (TCMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Company Profile

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Sector

Healthcare

Industry

Medical - Devices

Employees

1,037

IPO Date

2016-07-28

Beta

0.99

Websitewww.tactilemedical.com↗